Everolimus STADA 5 mg tablete
| Name | Everolimus STADA 5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-505763727 |
| Active Substance | everolimus |
| Composition | svaka tableta sadrži 5 mg everolimusa |
| Pharmaceutical Form | tableta |
| Manufacturer | Genepharm S.A., Pallini, Attiki, Grčka STADA Arzneimittel AG, Bad Vilbel, Njemačka STADA Arzneimittel GmbH, Beč, Austrija Pharmadox Healthcare Limited, Paola, Malta Pharmacare Premium Ltd., Birzebbugia, Malta |
| Marketing Authorisation Holder | Stada d.o.o., Hercegovačka 14, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.04.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/93 |
| Registration Number | 381-12-01/171-23-02 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EG02 |
| Medicinal product marketed in the Croatia | Privremeni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
